WealthCare Investment Partners’s iShares Biotechnology ETF IBB Stock Holding History

WealthCare Investment Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.04M	Buy	21,243 +2,928	+16%	+$503K	0.98%	28
2026 Q1	$3.04M	Buy	18,315 +3,959	+28%	+$677K	0.84%	33
2025 Q4	$2.43M	Buy	14,356 +434	+3%	+$70.5K	0.71%	43
2025 Q3	$2.07M	Buy	13,922 +984	+8%	+$134K	0.67%	44
2025 Q2	$1.68M	Buy	12,938 +926	+8%	+$114K	0.6%	46
2025 Q1	$1.41M	Buy	12,012 +1,664	+16%	+$226K	0.6%	49
2024 Q4	$1.38M	Buy	10,348 +96	+0.9%	+$13.5K	0.6%	43
2024 Q3	$1.46M	Buy	10,252 +281	+3%	+$40.7K	0.64%	42
2024 Q2	$1.37M	Buy	9,971 +401	+4%	+$53.5K	0.64%	42
2024 Q1	$1.31M	Buy	9,570 +527	+6%	+$72K	0.63%	40
2023 Q4	$1.26M	Buy	9,043 +343	+4%	+$41.8K	0.69%	40
2023 Q3	$1.05M	Buy	8,700 +425	+5%	+$54K	0.64%	41
2023 Q2	$1.05M	Buy	8,275 +94	+1%	+$12.2K	0.63%	42
2023 Q1	$1.06M	Buy	8,181 +528	+7%	+$69.1K	0.64%	45
2022 Q4	$1M	Buy	7,653 +265	+4%	+$34.2K	0.68%	39
2022 Q3	$864K	Buy	7,388 +204	+3%	+$25.3K	0.71%	43
2022 Q2	$845K	Buy	7,184 +1,451	+25%	+$172K	0.72%	44
2022 Q1	$760K	Sell	5,733 -576	-9%	-$75K	0.68%	45
2021 Q4	$963K	Buy	+6,309	New	+$977K	0.93%	32

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

WealthCare Investment Partners's IBB Position: Q2 2026 in Review

WealthCare Investment Partners increased its iShares Biotechnology ETF (IBB) stake by 16% in Q2 2026, buying an estimated $503K and bringing the position to 21,243 shares worth $4.04M. The position accounts for 0.98% of the portfolio, ranked #28.

WealthCare Investment Partners first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

WealthCare Investment Partners held 21,243 shares of iShares Biotechnology ETF worth $4.04M as of Q2 2026.
WealthCare Investment Partners bought 2,928 iShares Biotechnology ETF shares in Q2 2026, an estimated $503K.
iShares Biotechnology ETF made up 0.98% of WealthCare Investment Partners's portfolio in Q2 2026, its #28 holding.
WealthCare Investment Partners first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on WealthCare Investment Partners's 13F filing for Q2 2026, filed 10 Aug 2026.